EUVIMEDEUVIMED entdecken
Crossref

Artificial intelligence in metabolic dysfunction-associated steatotic liver disease: A short narrative review of diagnostic and therapeutic implications

Mona Mohamed Ibrahim Abdalla, Fabian Davamani, Nabil Eid

Artificial Intelligence in Gastroenterology · 08.11.2026 · 7 (3)

DOI: 10.35712/aig.124329 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Artificial Intelligence in Gastroenterology, online erschienen am 08.11.2026. Verfasst von Mona Mohamed Ibrahim Abdalla und 2 weiteren Autor:innen. Die Arbeit nennt 59 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatotic liver disease is the most prevalent chronic liver disease worldwide and may progress from steatosis to metabolic dysfunction-associated steatohepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma. Insulin resistance, obesity, mitochondrial dysfunction, inflammation, and impaired autophagy contribute to its pathogenesis. Early diagnosis, monitoring of disease progression, and assessment of therapeutic response remain important clinical challenges. Artificial intelligence (AI) and machine learning may improve disease prediction by integrating laboratory, metabolic, imaging, histological, and molecular data. Natural language processing and deep-learning approaches applied to radiological imaging and digital histopathology may support automated quantification of steatosis, inflammation, and fibrosis, while AI-assisted multi-omics analysis may identify molecular signatures relevant to disease stratification. Current evidence is strongest for retrospective case identification, imaging-based classification, and quantitative digital pathology; therapeutic selection and monitoring remain largely investigational. AI should therefore be viewed as a decision-support technology rather than a replacement for clinical judgment.

Zitieren

APA

Abdalla, M. M. I., Davamani, F., & Eid, N. (2026). Artificial intelligence in metabolic dysfunction-associated steatotic liver disease: A short narrative review of diagnostic and therapeutic implications. Artificial Intelligence in Gastroenterology, 7(3). https://doi.org/10.35712/aig.124329

Vancouver

Abdalla MMI, Davamani F, Eid N. Artificial intelligence in metabolic dysfunction-associated steatotic liver disease: A short narrative review of diagnostic and therapeutic implications. Artificial Intelligence in Gastroenterology. 2026;7(3). doi:10.35712/aig.124329

BibTeX
@article{Abdalla2026,
  author = {Abdalla, Mona Mohamed Ibrahim and Davamani, Fabian and Eid, Nabil},
  title = {Artificial intelligence in metabolic dysfunction-associated steatotic liver disease: A short narrative review of diagnostic and therapeutic implications},
  journal = {Artificial Intelligence in Gastroenterology},
  year = {2026},
  volume = {7},
  number = {3},
  doi = {10.35712/aig.124329}
}
Kostenlos starten →